Osgood-Schlatter Disease Clinical Trial
Official title:
Phase 2 Study of Dextrose Injection for Sport-Limiting Osgood Schlatter Disease in Adolescents.
Objective: To examine the potential of dextrose injection versus lidocaine injection versus supervised usual care to change pain/function/activity levels in adolescent athletes with Osgood-Schlatter Disease (OSD).
Patients and methods: Girls ages 9-15 years old and boys ages 10-17 years old will be assigned to either therapist-supervised usual care, or to double-blind injection of 1% lidocaine solution with or without 12.5% dextrose. Injections will be administered monthly for three months. All subjects will then be offered dextrose injections monthly as needed. Change in the Nirschl Pain Phase Scale (NPPS) will serve as the primary outcome measure. ;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04716608 -
Treatment for Osgood Schlatter Patients With a Physiotherapy Program
|
N/A | |
| Completed |
NCT03589001 -
24 Month Follow-up of Patients With Osgood Schlatter (OSD)
|
||
| Recruiting |
NCT05826340 -
Getting Kids With Osgood Schlatter Back to Performing Without Pain
|
N/A | |
| Active, not recruiting |
NCT05174182 -
A Comparison of Two Different Treatment Approaches for Adolescents With Osgood Schlatter
|
N/A | |
| Completed |
NCT05789095 -
Rate of Torque Development in Adolescents With Osgood-Schlatter
|